For senior adults, the complications associated with constipation and abnormal bowel movement can become quite frustrating with the aging process. Fluctuations in gastrointestinal processes can leave many elderly adults in a state of flux, often impairing activities of daily living.
In an effort to resolve complications associated with chronic constipation, the FDA has approved the use of a prescription drug known as Amitiza. Distributed by Sucampo Pharmaceuticals, Amitiza provides all adults, including those over the age of 65, with relief from constipation of an idiopathic nature.
As a convenient method for dosing prescription medication in the treatment of chronic constipation, Amitiza can be utilized twice daily, in doses of 24 micrograms tablets.
As with any FDA approved drug, Amitiza, in the treatment of chronic constipation, does not come without side effects. Most commonly, patients report side effects including diarrhea, nausea and vomiting with some patients reporting intermittent headache pain. However, these side effects are generally indicated in the higher doses of Amitiza and often dissipate over the course of treatment.
As a category C drug classification, Amitiza has gained conflicting results in controlled studies of the effects of this therapeutic drug on a developing fetus and pregnancy. As a result, women who are pregnant, or may become pregnant, should avoid the use of Amitiza unless there are no other options available.
For patients who suffer from complications associated with gastrointestinal complications, other than that of chronic idiopathic constipation, should be evaluated and managed closely to ensure the use of Amitiza is appropriate for their condition. Additionally, individuals who suffer from neurological disorders, disorders involving the respiratory system, vascular or metabolic complications, skin disorders and even complications associated with hearing, should avoid the use of Amitiza for chronic idiopathic constipation. Should Amitiza be utilized in these patients, careful planning and management of the medication use is highly recommended so as to prevent the further exacerbation of the co-morbid health complication.
While Amitiza is providing great relief of constipation in the elderly population, it has not been tested or approved for use in children. As a result, if you are caring for a child who suffers from chronic idiopathic constipation, it may be necessary to look at other treatment options.
As with any gastrointestinal complication, the key to optimal health and recovery, especially as an elderly adult, is to seek out the early diagnosis and intervention from a healthcare professional. When determined to suffer from a chronic idiopathic constipation, discuss the options for medication management, including the use of FDA prescription drug, Amitiza.